| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| HAMILTON THORNE Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 319,00 | +1,05 % | ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine | ||
| UNITEDHEALTH | 345,00 | +0,88 % | UnitedHealth-Aktie: Ende der Abwärtsbewegung? | Die UnitedHealth-Aktie hat ihre jüngste Schwächephase bis unter 400 US$ ausgedehnt, drehte jedoch noch deutlich vor der wichtigen Unterstützung bei 376,22 US$ wieder nach oben. Mit aktuell 403,43 US$... ► Artikel lesen | |
| MEDTRONIC | 81,98 | +1,09 % | Ihre wichtigsten Termine: Medtronic, Swiss Life, Gerresheimer & Paolo Alto Networks stehen heute im Fokus! | © Foto: picture alliance/ASSOCIATED PRESS/Gerresheimer AG - picture alliance/ASSOCIATED PRESS/Gerresheimer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick... ► Artikel lesen | |
| TELADOC HEALTH | 5,442 | +0,70 % | Here's Why Teladoc's Integrated Care Business Deserves More Attention | ||
| SERNOVA BIOTHERAPEUTICS | 0,067 | -5,11 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| HCA HEALTHCARE | 344,80 | -1,12 % | HCA Healthcare (HCA) Navigates Patient Volume Challenges While Reporting Growth | ||
| LANTHEUS | 86,50 | -0,57 % | Lantheus Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| CAREDX | 44,000 | +0,46 % | Canaccord initiates CareDx stock coverage with buy rating on testing | ||
| ENVISTA | 23,800 | +0,85 % | Envista Aktie steigt nach Hochstufung durch JPMorgan | ||
| GT BIOPHARMA | 0,242 | +0,33 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.09.2026 | Das Instrument R1EA AU0000196206 EV RESOURCES LTD. EQUITY wird cum Kapitalmassnahme gehandelt am 07.09.2026 und ex Kapitalmassnahme am 08.09.2026 The instrument R1EA AU0000196206 EV RESOURCES LTD. EQUITY... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Causaly and Syneos Health Partner to Raise the Scientific Intensity of Clinical Research | Collaboration embeds evidence-grounded agentic AI into scientific workflows across Syneos Health, accelerating research while strengthening scientific rigor, consistency, and sponsor valueLONDON... ► Artikel lesen | |
| CARMAT | 0,049 | 0,00 % | CARMAT SAS: EFICAS Study Results Confirm the Clinical Performance of the Aeson Total Artificial Heart as a Bridge-to-Transplant Therapy | The study's primary endpoint was achieved in 72.7% of the 55 patients implanted between December 2022 and May 2025.
This rate was significantly above the historical benchmark of 38% established... ► Artikel lesen | |
| CHEMOMETEC | 69,40 | +1,54 % | ChemoMetec A/S: ChemoMetec enters collaboration agreement with Roche Diagnostics | ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming to pursue a collaboration with the goal of creating synergies between the parties' solutions in... ► Artikel lesen |